title: [Conservative therapy of malignant pleural effusion].
abstract: The nonsurgical treatment of malignant pleural effusion is palliative in principle. This aim must be achieved with a minimum of side effects and risks to the patients. Before treatment, a clear histologic diagnosis must be made. Thoracoscopy offers a fast and safe result with a more than 90% reliability. Systemic cytotoxic treatment and local procedures are available. Using pleurodesis, talkum is clearly superior to tetracycline in achieving a very low recurrence rate. The median survival in 287 patients was 9 months.
authors.affiliation: Pneumologische Abteilung, Lungenklinik Hemer.
authors.forename: H N
authors.initials: HN
authors.lastname: Macha
authors.forename: G
authors.initials: G
authors.lastname: Reichle
mesh_terms: D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D006801:Humans; D010166:Palliative Care; D016066:Pleural Effusion, Malignant / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate; D013906:Thoracoscopy
vernacular_title: Die konservative Therapie des malignen Pleuraergusses.